Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. - Wikidata - wikimedia - TriplyDB

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.

http://www.wikidata.org/entity/Q36807962

about

GlcNAcstatins are nanomolar inhibitors of human O -GlcNAcase inducing cellular hyper- O -GlcNAcylation O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling Study of vascular injuries using endothelial denudation model and the therapeutic application of shock wave: a review.O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response O-GlcNAc mediated glycosylation down-regulation in mice with cyclophosphamide induced cystitis.O-GlcNAc modification of NFκB p65 inhibits TNF-α-induced inflammatory mediator expression in rat aortic smooth muscle cells Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response†.O-GlcNAc signaling in the cardiovascular system.O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Protein O-GlcNAcylation and cardiovascular (patho)physiology.O-GlcNAcylation and Inflammation: A Vast Territory to Explore Increased O-linked beta-N-acetylglucosamine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Glucosamine Downregulates the IL-1β-Induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-GlcNAc Modification-Dependent and -Independent Mechanisms.Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling.Use of glucosamine and chondroitin in relation to mortality Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.O-linked beta-N-acetylglucosamine during hyperglycemia exerts both anti-inflammatory and pro-oxidative properties in the endothelial system Cardiomyocyte Ogt is essential for postnatal viability.O-GlcNAc and the cardiovascular system.Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.Chemical tools to explore nutrient-driven O-GlcNAc cycling.O-GlcNAcylation and cardiovascular disease.Short-term glucosamine infusion increases islet blood flow in anesthetized rats.Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.Down-regulation of IL-6, IL-8, TNF-α and IL-1β by glucosamine in HaCaT cells, but not in the presence of TNF-α The paradoxical world of protein O-GlcNAcylation: a novel effector of cardiovascular (dys)function.Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis.Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.Modulation of O-GlcNAc levels in the liver impacts acetaminophen-induced liver injury by affecting protein adduct formation and glutathione synthesis.

P2860

Q27654050-D5401D2D-9319-4D5C-B824-5976171FB37C Q27693206-5DB42632-A3BB-421E-A55B-9DD250EDBF9D Q28569862-00E1787E-40A3-43D6-BBF2-430FE8E309DC Q28581505-7F5E98AA-F0C5-44F7-9DF7-FB363B2072B4 Q30475246-D460E11A-5506-4F10-A8C4-EBA34F5AA12C Q33599905-CD96DE87-AA03-4DB5-99F8-112F0A8BE45A Q33722663-FA3CC6E5-AF3A-446B-86CC-5401802AF5E6 Q33732445-5A4233E4-B89D-47B5-8EDE-9742569EAC42 Q34014467-06BE93B8-3C6F-4A4C-B89B-F898DC9135ED Q34048268-5ECE1AEC-5F0C-4391-96AD-3BB1D58C98C2 Q34056858-628683B1-4B57-4542-8E92-5703202015C7 Q34101859-C7F2D9C3-C7D4-4672-B767-C560E0B65B66 Q34498193-D62C1119-9BA0-40D0-BC82-8D1C091188A5 Q34598611-EBA99CF0-D4A3-4A46-859E-D1C6E569C1A5 Q34683061-6168D387-2C15-4A49-9224-2693F3F1BA30 Q34885671-CCBA2BC4-4530-4FF7-8827-D10381D889FB Q35282231-F8706900-302F-4C52-B0A5-BB986EAAF8CC Q35804446-B07162C3-0EE4-449C-8910-71ED2A5F1AC1 Q35994096-06E6D711-E93A-4598-8A7E-CF52BF7E83F0 Q36173158-A8C2E577-0191-447A-BF60-6DCDA9B60EA9 Q36309320-C9C1F523-E200-4EFE-883E-8FD6A4B9DDE4 Q36342142-B433EE70-C246-4019-B67D-05ED064C291A Q36570336-D08AF9CA-43C1-45E5-999F-CD853A6C630D Q37088282-7AA26B51-281C-4069-A003-3B1709B331A0 Q37099485-6882316F-FDA8-4C15-8159-03171E717E21 Q37349166-FC1AC76D-CB0E-417A-B58F-68529EC91299 Q37390284-96DD1098-D5A7-4CBD-A233-63127587272A Q37575982-F3105C78-E2A7-4D5F-8719-14A9CFEC9DDF Q37619691-94CFE7AC-FD7A-4B70-89E4-F5A307F1BBE2 Q37924015-4AF20ED3-E837-4B80-B412-96FD8EB04DBA Q38231368-1F61B552-367B-4063-A061-E2D21A7014D4 Q39241584-58E8E630-169C-469A-8040-F4160179A0D9 Q39246006-44F48CC3-2D49-4622-8054-D4288BFB8907 Q39298645-5EEAA39D-1E7B-49FB-A8BB-F7C737A4EA77 Q40794510-76578D25-480B-45A3-A567-866AC639085A Q42323720-A6CE050F-611B-4873-A367-E7ED36B4B31E Q42583228-7DB1C746-6F65-44EC-8547-F4AB02706FD7 Q46027542-54CB1BC6-05DA-4EB6-BCC0-D420504A62A4 Q48423896-5FBED5D0-EFB6-4C1B-A2CB-BF2B6B21FCB3 Q50083933-0273D1C3-48E4-4FC5-BC82-42417FCE0AB3

P2860

Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.

http://www.wikidata.org/entity/Q36807962

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@ast

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@en

type

label

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@ast

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@en

prefLabel

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@ast

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@en

P1433

Q36807962-00B8DAA2-2E92-419C-9EC7-5F61A79CC39E

P1476

Q36807962-7F4F65DE-0511-4DB3-A70A-81CC2854BA6A

P2093

Q36807962-161D4CED-5264-4DEE-8EEA-3FB1CDF4D7F7

Q36807962-27CA8AB6-E10B-4177-9795-38A6BE4CC386

Q36807962-586602FD-53A3-4654-BDFB-094F414A842C

Q36807962-6000D37B-51B3-4F5B-8760-87841EA56B14

Q36807962-A61CB490-049D-499B-A7D9-F3CC4DA42DC7

Q36807962-AC279EA0-8523-4E82-9D6A-ECDD0FC87C1B

Q36807962-D4C8704F-9754-4EE7-B07E-68E181A50547

Q36807962-EAAAF281-6C72-4057-A62B-5D8B33A6EC0D

Q36807962-FEB30815-20E3-4E4C-B0B6-061CD4DE104D

P2860

Q36807962-00403138-F630-463E-BCC3-420F48D5365D

Q36807962-0375D0B2-E38A-4C52-A8AA-114FF1C110EC

Q36807962-079C741E-B4D4-4B36-9E6F-7B2AA9E27555

Q36807962-0CCA323F-766B-4BD2-BDC3-C8AD1B2AA1BB

Q36807962-0D5A0BBD-665D-46A8-9FCB-CE01A919BE3B

Q36807962-168E4DBF-3BEF-40B7-9B96-61F16FC0ADF7

Q36807962-26C5CB04-40DC-4EB3-85B6-5EECA509F765

Q36807962-2F96F7F6-69E9-4842-824D-B3D5E6314188

Q36807962-31741210-A2B8-4E2E-9DE2-9CF77E218EAC

Q36807962-358B9CAA-CDD0-4F8C-84CD-5E4EC3B73C1D

P304

Q36807962-1DC2340B-7F06-4FA1-B0FE-BC3405A4A538

P31

Q36807962-AF78427E-1AC0-4134-ACBC-C21F41FB7662

P356

Q36807962-71E2D846-2249-406B-8882-132504A1C4F3

P433

Q36807962-716218E9-7664-4DF4-B0B9-C13891D89299

P478

Q36807962-5EE148B3-5F25-40A5-B5FA-748968E8ED06

P577

Q36807962-9099EEB5-4039-4129-92EF-ABF8A671E914

P5875

Q36807962-BEBF7846-AAF5-477C-A539-2FF9DBB9FC1D

P698

Q36807962-DA40BF49-53B4-4A38-B7ED-D9844E405099

P932

Q36807962-18F0D75E-BECD-4691-B8A6-87B5A0AF49F1

P356

AJPHEART.01259.2007

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Increased protein O-GlcNAc mod ...... e endoluminal arterial injury.

@en

P2093

Andrew P Miller

http://www.w3.org/2001/XMLSchema#string

Dongqi Xing

http://www.w3.org/2001/XMLSchema#string

Erum Majid-Hassan

http://www.w3.org/2001/XMLSchema#string

John C Chatham

http://www.w3.org/2001/XMLSchema#string

Laszlo G Nöt

http://www.w3.org/2001/XMLSchema#string

Suzanne Oparil

http://www.w3.org/2001/XMLSchema#string

Wenguang Feng

http://www.w3.org/2001/XMLSchema#string

Yiu-Fai Chen

http://www.w3.org/2001/XMLSchema#string

Yun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain

Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis

Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc

Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation

IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia

Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats

Inflammation in atherosclerosis

Glycan-dependent signaling: O-linked N-acetylglucosamine

Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

P304

H335-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.01259.2007

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

295

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5382691

http://www.w3.org/2001/XMLSchema#string

P698

18469144

http://www.w3.org/2001/XMLSchema#string

P932

2494765

http://www.w3.org/2001/XMLSchema#string